Induction of immortal-like and functional CAR-T cells by defined factors
L. Wang, G. Jin, Q. Zhou, Y. Liu, X. Zhao, Z. Li, N. Yin, M. Peng
Abstract
Long-term antitumor efficacy of chimeric antigen receptor (CAR)-T cells depends on their functional persistence in vivo. T cells with stem-like property show better persistence, but factors conferring T cells bona fide stemness remain to be determined. Here, we demonstrate the induction of CAR-T cells into an immortal-like and functional state, termed TIF. The induction of CAR-TIF cells depends on repression of two factors: BCOR and ZC3H12A, and requires antigen or CAR tonic signaling. The reprogrammed CAR-TIF cells possess almost infinite stemness resembling induced pluripotent stem cells but retain functionality of mature T cells, which exhibit superior antitumor effect. CAR-TIF cells enter a metabolically dormant state after elimination of target cells, which persist in vivo with a saturable niche and mediate memory protection. CAR-TIF cells represent a novel state of T cells with unprecedented stemness conferring long-term functional persistence of CAR-T cells in vivo, which have broad potentials in T cell therapies.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting ZC3H12C improves T cell persistence and antitumor function in adoptive T cell therapy
Gayatri Kavishwar, Markus Perl, … Christian Schmidl·bioRxiv·May 2, 2026
- Transient "rest" induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells
E. W. Weber, R. C. Lynn, … C. L. Mackall·bioRxiv·Jan 26, 2020
- CTLA-4 tail fusion enhances CAR-T anti-tumor immunity
- BACH2 dosage establishes the hierarchy of stemness and finetunes antitumor immunity in CAR T cells
Taidou Hu, Ziang Zhu, … Tuoqi Wu·Nature ImmunologyPeer-reviewed·Jan 16, 2026
- Decade-long remissions of leukemia sustained by the persistence of activated CD4+ CAR T-cells
J. J. Melenhorst, G. M. Chen, … C. H. June·bioRxiv·May 7, 2021
- Dendritic cells accelerate CAR T cells in irradiated tumors through chimeric synapses
Sammy Navarre, Maki Ishibashi, … Jalal Uddin Ahmed·Nature CancerPeer-reviewed·May 22, 2026